Ligelizumab Terminated Phase 2 Trials for Asthma Bronchial Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02336425Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma
NCT02075008Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201